Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilizing Devyser's unique assays in its CLIA-certified laboratory. The companies will work together to promote the Devyser laboratory services to support and advance research and development for pharmaceutical companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.8 SEK | -2.63% | 0.00% | +26.97% |
05-14 | Devyser Diagnostics AB Appoints Thomas Eklund as Member of the Board of Directors | CI |
05-08 | Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024 |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
595.3 USD | -0.31% | +0.38% | 227B | ||
99.8 SEK | -2.63% | 0.00% | 152M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.97% | 152M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- DVYSR Stock
- News Devyser Diagnostics AB
- Devyser and Thermo Fisher Scientific Collaborate to Promote Laboratory Services to Advance Pharmaceutical Research